Table 2.
IFN-γ (ng/ml) | 0 | 20 | 40 | 80 |
---|---|---|---|---|
CD4+CD25+ (%) | 18.3 ± 4.1** | 29.2 ± 3.1*,** | 43.1 ± 3.7* | 32.3 ± 4.5*,** |
* P < 0.05 vs. 0 ng/mL IFN-γ induced CD4+CD25+ T cells (%). ** P < 0.05 vs. 40 ng/mL induced CD4+CD25+ T cells (%)
IFN-γ (ng/ml) | 0 | 20 | 40 | 80 |
---|---|---|---|---|
CD4+CD25+ (%) | 18.3 ± 4.1** | 29.2 ± 3.1*,** | 43.1 ± 3.7* | 32.3 ± 4.5*,** |
* P < 0.05 vs. 0 ng/mL IFN-γ induced CD4+CD25+ T cells (%). ** P < 0.05 vs. 40 ng/mL induced CD4+CD25+ T cells (%)